Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency from Tuesday, to help improve our understanding of immunity against COVID-19 from vaccination and infection.
Anyone aged over 18 will be able to opt in to take part when booking a PCR test through NHS Test and Trace. Up to 8,000 people who opt in and then receive a positive PCR result will be sent two finger prick antibody tests to complete at home and send back to a lab for analysis.
The UK Health Security Agency will work alongside NHS Test and Trace testing services in England, Scotland, Wales and Northern Ireland to monitor levels of antibodies in positive cases across the UK. The data collected will help estimate the proportion of those who got COVID-19 despite developing antibodies as a result of having a vaccine or previously catching coronavirus.
The initiative could also provide insight into any groups of people who do not develop an immune response. The UK Health Security Agency will use the data to inform our ongoing approach to COVID-19 and provide further insight into the effectiveness of the vaccines against different variants.
Health and social care secretary Sajid Javid said: “Our new national antibody testing will be quick and easy to take part in, and by doing so you’ll be helping strengthen our understanding of COVID-19 as we cautiously return to a more normal life.
“I’m proud to see all parts of the UK uniting around this new initiative and working together to arm ourselves with even more valuable insights into how COVID-19 vaccines are protecting people up and down the UK.
“Our phenomenal vaccination programme continues to build a massive wall of defence across the country – already preventing around 24 million infections and more than 100,000 deaths in England alone. I urge everyone across the UK to get both vaccinations as soon as possible.”
All adults interested in the study are encouraged to opt in. Anyone taking part must take their first antibody test as soon as possible after receiving a positive PCR result, before the body has had time to generate a detectable antibody response to the current infection. The first test will determine the level of antibodies a person had before their current infection.
The second test should be taken 28 days after testing positive for COVID-19 and will measure antibodies generated in response to the infection. By comparing the two antibody test results, the UK Health Security Agency will be able to see how well vaccinated individuals boost their immunity when they are infected and how this might vary with different variants.
Testing positive for antibodies does not mean someone is immune from COVID-19 and people must continue to follow the rules, get tested if they have symptoms and self-isolate if positive or are a contact of a positive case and have not received both vaccine doses, to prevent the virus from spreading.
Chief executive of the UK National Health Security Agency Dr Jenny Harries said: “We are rolling out antibody testing across the UK to gain vital data into the impact of our vaccination programme and on immune responses to different variants of COVID-19.
“This innovative programme is only possible thanks to the thousands of people who continue to help with studies on vaccine and treatment effectiveness each week.
“The best way to protect yourself and those around you is by getting vaccinated. I encourage anyone who has not yet come forward to book their first and second jabs.”
The NHS has guidance on what you can do to look after yourself and treat any symptoms you may have following a positive PCR result. It remains vital people continue to get a PCR swab test if they have symptoms and self-isolate when asked by NHS Test and Trace. Individuals should not change their behaviour based on an antibody result.
Antibodies are part of the body’s immune response to help fight off infection and are generated either after being infected or following vaccination. Antibody testing looks for evidence of this immune response, whereas PCR and antigen testing tells someone if they have the virus at the time of test.
Antibody testing will contribute to our understanding of the protection provided by vaccines.
Geoff Twist, managing director of Roche Diagnostics UK & Ireland, said: “We are proud that our antibody tests are being used as part of the new UK-wide surveillance programme, helping to improve understanding of immunity against COVID-19 from vaccination and infection. Diagnostic testing has played a crucial role during the pandemic, and this latest data will help estimate the proportion of those who have caught COVID-19 despite developing antibodies. We have supported the ongoing national effort with a number of different diagnostic solutions over the last 18 months, and we are very pleased that our test will be part of this latest phase.”
